An essential feature of ®broblast growth factor receptors (FGFRs) is the existence of multiple possibilities of alternative splicing. One of these concerns sequences of the mRNA coding for the C-terminal half of Ig domain 3 which corresponds to a part of the ligand-binding site: two alternative exons, IIIb and IIIc, encode the Cterminal half of Ig domain 3. The IIIb/IIIc choice in the FGFR-2 and FGFR-3 is strictly tissue-speci®c, the IIIb exon being expressed exclusively in epithelial cells. We describe here a reversible switch from IIIb to IIIc for FGFR-2 and FGFR-3 under the in¯uence of exogenous and endogenous FGF-1 or FGF-2. We observed that FGF-induced FGF receptor exon switching (i) occurred as early as 1 h after exposure to FGF (ii) was receptormediated (iii) was dependent on cell con¯uency and showed a link with the cell cycle (iv) was correlated with a reversible loss of epithelial properties. These results support a role for FGF in the regulation of expression of alternatively spliced FGFR mRNA.
Introduction
The ®broblast growth factors (FGFs) are a family of heparin-binding polypeptides that play dierent roles, including the stimulation of cell proliferation and mobility, induction or inhibition of cell dierentiation and cell survival (for reviews see Burgess and Maciag, 1989; Basilico and Moscatelli, 1992) . The biological activities of the FGFs, including the signal peptide-less prototypes, FGF-1 (acidic) and FGF-2 (basic), are mediated through high anity cell surface-associated FGF receptors (FGFRs). To date, four related genes encoding high anity FGF receptors have been identi®ed (FGFR-1 to FGFR-4). These receptors share a highly homogenous intracellular tyrosine kinase domain and an extracellular domain including two or three immunoglobulin-like (Ig) domains (for reviews see Jaye et al., 1992; Johnson and Williams, 1993) .
A multitude of variants of these FGFRs are generated by alternative splicing. A particularly interesting alternative splice concerns sequences of the mRNA coding for the C-terminal half of Ig domain 3, as this region of the receptor is part of the ligandbinding site. The Ig domain 3 is encoded by two separate exons: the exon IIIa encodes the N-terminal half while two alternative exons, denoted IIIb and IIIc, code for the C-terminal half. The alternative utilization of exon IIIb or IIIc results in striking dierences in the ligand-binding speci®cities of the resulting receptor forms. While the IIIb and the IIIc variants of the FGFR-1 bind FGF-1 with high anity, the IIIb variant has a 50-fold lower anity for FGF-2 than does the IIIc variant (Werner et al., 1992) . Alternative splicing of IIIb or IIIc exons of the FGFR-2 also results in dierential anities for FGF ligands. The IIIb variant of FGFR-2, also called keratinocyte growth factor receptor (KGFR) is a high anity receptor for FGF-1 and FGF-7, while use of the IIIc exon yields a receptor (also called BEK) with high anity for FGF-1 and FGF-2, but not for FGF-7 (Dionne et al., 1990; Houssaint et al., 1990; ChampionArnaud et al., 1991; Miki et al., 1992; Yayon et al., 1992; Yan et al., 1993) . Distinct anities for the FGFs have also been described for the variants of the FGFR-3: the IIIc variant preferentially binds FGF-1 and FGF-4, with very little response to FGF-2 and no response to FGF-5 (Ornitz and Leder, 1992) , while the IIIb variant binds only FGF-1 (Chellaiah et al., 1994) . In contrast, the FGFR-4 gene was shown to lack two alternative exons for Ig domain 3 and to contain only exon IIIc. This FGFR-4 binds FGF-1 with high anity but shows low anity for FGF-2 (Vainikka et al., 1992) .
It was established by dierent groups that the choice between IIIb and IIIc exons of the FGFR-2 is a mutually exclusive alternative splicing choice, so that the two receptors, BEK and KGFR, seem never to be expressed together on the cell surface (ChampionArnaud et al., 1991; Miki et al., 1992; Yan et al., 1993) . In fact, the IIIb/IIIc choice is strictly correlated to the cell phenotype. Epithelial cells express only IIIb transcripts while ®broblastic cells express exclusively IIIc transcripts. Moreover we have shown that the epithelio-mesenchymal conversion induced by the activation of c-Fos, is accompanied by a de®nitive switch of the FGFR-2 from the IIIb to the IIIc type . In contrast, the use of IIIb or IIIc exon is not strictly tissue-speci®c for the FGFR-3 as epithelial cells show exclusively IIIb while ®broblastic cells show a mixture of IIIb and IIIc transcripts .
It was previously described that FGF-1 and FGF-7 could induce the rat carcinoma cell line NBT-II to undergo a reversible transition from epithelial to mesenchymal phenotype when the cells were cultured at low con¯uency (ValleÂ s et al., 1990; Jouanneau et al., 1991) . It was also demonstrated by this group that NBT-II cells activated for 1 week with FGF-1 switched from FGFR-2/IIIb to FGFR-2/IIIc (Savagner et al., 1994) . However, as NBT-II cells cultured at high density, without FGF-1, also switched to IIIc (Savagner et al., 1994) , it was not clear from this study if the FGF receptor exon switching could be induced by cell con¯uency as well as by FGF-1. This prompted us to reexamine the in¯uence of FGFs and of cell con¯uency on the IIIb/IIIc choice in the FGFR genes. Using two dierent epithelial cell lines, we show that exogenous and endogenous FGF-1 and/or FGF-2 induced a reversible switch from IIIb to IIIc for FGFR-2 and FGFR-3. This transient exon III switch appears to be cell cycle-dependent. We also show that cell con¯uency did not change the exon III choice for these two epithelial cell lines as con¯uent as well as subcon¯uent cells exclusively express the IIIb variant of FGFR-2 and -3.
Results

Analysis of expression of FGFRs in SVK14 and NBT-II cells
Expression of FGFRs was analysed in SVK14 cells, a human keratinocyte cell line and in NBT-II cells, a rat bladder carcinoma cell line, using Northern blotting and RT-PCR analysis. Speci®c primers were used to amplify sequences coding for the extracellular domain of human or rat FGFR-1, -2 or -3 ( Figure 1a) . Restriction enzyme analysis, using AvaI and HincII allowed the distinction between the IIIb or IIIc variant of FGFR-2 (Figure 1b, c) . The distinction between the IIIb or IIIc variant of FGFR-3, using HaeII and TaqI, has been described previously . Northern blot analysis of total RNA from SVK14 cells revealed expression of FGFR-1 which was identi®ed as a major transcript of 4.5 kb (Figure 2a ), while FGFR-2 transcripts remained undetectable. PCR ampli®cation of the region of the corresponding cDNAs coding for the extracellular domain of the FGFR-1 revealed that both the two (FGFR-1b) and the three (FGFR-1a) Ig domain FGFR-1 isoforms (Hou et al., 1991) were expressed in SVK14 cells (Figure 2b ). PCR ampli®cation of the extracellular domain of FGFR-2 showed that three variants were expressed, corresponding to the form with two Ig domains, with or without the acidic box, and to the form with three Ig domains (Figure 2c ). Restriction enzyme analysis showed that these FGFR-2 transcripts were exclusively IIIb. PCR ampli®cation of FGFR-3 cDNA coding for Ig domain 3 and transmembrane domain showed that the FGFR-3 transcripts were also exclusively IIIb (Figure 2d ).
Northern blot analysis of total RNA from NBT-II cells showed expression of FGFR-2 transcripts ( Figure  2e ), while FGFR-1 transcripts were undetectable. PCR ampli®cation of the extracellular domain of the FGFR-1 resulted in no signal in NBT-II cells while positive control with cDNA from rat ®broblasts, using the same primers, resulted in two products of 1.15 and 0.88 kb, corresponding respectively to the forms with three or two Ig domains (not shown). PCR amplification of the extracellular domain of FGFR-2 showed expression of the two and three Ig domain isoforms of the IIIb variant (Figure 2f ). In summary, it appears from the Northern blot analysis that SVK14 cells express FGFR-1 while NBT-II cells express FGFR-2. RT-PCR analysis allowed the exclusive detection in these two cell lines of the IIIb variant of the FGFR-2. These two cell lines were submitted to exogenous or endogenous FGF-1 and -2 and we searched if a switch from IIIb to IIIc could be observed for FGFR-2. A similar analysis was conducted for FGFR-3 in SVK14 cells. FGFR-1 was not analysed in this study as epithelial cells as well as mesenchymal cells express predominantly the IIIc variant (Werner et al., 1993) .
Exogenous FGF-1 or FGF-2 induces a IIIb to IIIc switch of the FGFR-2 in SVK14 cells SVK14 cells, seeded at low density or at con¯uency, received one addition of FGF-1 or FGF-2 (18 kDa) and were cultured for various times, ranging from 30 min to 48 h. RT-PCR analysis of the FGFR-2 transcripts was then performed. Each experiment was repeated at least four times. When SVK14 cells, seeded at low density, were cultured in presence of exogenous FGF-1 or FGF-2, we observed a partial IIIb to IIIc switch for the FGFR-2 transcripts corresponding to the 3 Ig domain form, while cells cultured at low density in standard medium showed only IIIb transcripts (Figure 3a) . In contrast, when the cells were at con¯uency before addition of FGF-1 or FGF-2, we did not see any switch, that is no appearance of IIIc exons, whatever the time of exposure to FGF (Figure 3c ). The switch to IIIc was observed as early as 1 h after addition of FGF (Figure 3d ). It was still observed 3 h or 5 h, but no more 7 h or 10 h after addition of FGF (Figure 3f ). In contrast, some IIIc transcripts were observed 20 h (Figure 3g ), but no more 48 h (Figure 3h ), after addition of FGF. For each time point, we repeated the experiment at least four times. These observations were strictly similar for FGF-1 and FGF-2. It should be noticed that only a fraction of the transcripts switched from IIIb to IIIc, whatever the moment of analysis after addition of the growth factor. Addition of FGF, once per hour, during 6 h or addition of FGF, once per day, during three consecutive days did not increase the proportion of IIIc transcripts.
It appears from these data that exogenous FGF-1 and FGF-2 induced a partial and transient IIIb to IIIc switch in the FGFR-2, provided the cells were subcon¯uent. This was accompanied by a transient modulation of epithelial features of the SVK14 cells which lost their cell contacts, became scattered and acquired a ®broblastic morphology (not shown). P-labeled FGFR-2 cDNA and exposed for 3 days shows a major transcript of 4.5 kb. After removing the FGFR-2 probe, the blot was hybridized with a FGFR-1 probe and exposed for 10 days but no signal was detectable. (f and g) RT ± PCR analysis of FGFR-2 in NBT-II cells. (f) Three bands of 1.03, 0.77 and 0.69 kb were obtained using P7 and P8, corresponding to the two or three Ig domain forms and they were cut by AvaI. (g) One band of 0.59 kb was obtained using P9 and P8 and was cut by AvaI, indicating only IIIb transcripts Endogenous FGF-1 or FGF-2 induces a IIIb to IIIc switch of the FGFR-2 in SVK14 cells SVK14 cells were then transfected with several expression vectors encoding various forms of FGF-2. Four forms of FGF-2 have been described resulting from alternative initiation of translation at an AUG codon or at three upstream CUG codons, leading respectively to synthesis of a small form of 18 kDa or of large forms of 22, 22.5 and 24 kDa (Prats et al., 1989) . We used the plasmid pFGF-2neo, coding for the four forms of FGF-2 (Prats et al., 1989) . We also used three mutated FGF-2 cDNAs: the plasmid pRF11AEN coding for the small form of 18 kDa initiated at the AUG codon (Bugler et al., 1991) , the plasmid pRFEneo, coding for the large form of 24 kDa initiated at the CUG1 codon (Bugler et al., 1991) and the plasmid pIgbFGF, coding for a secreted 18 kDa FGF-2 (Rogelj et al., 1988) . Production of FGF-2 was analysed by immunoblotting in SVK14 cells transfected with the dierent plasmids as well as in control cells transfected with a vector containing a neomycine resistance gene alone (pSGneo). As shown in Figure  4 , pSGneo-transfected SVK14 cells produced predominantly the forms initiated at CUG2 and 3 (22.5 kDa), although very weak bands corresponding to the two other forms (18 and 24 kDa) were detectable. Analysis of production of FGF-2 by clones derived from the dierent categories of FGF-2-transfected cells showed that in the pFGF-2neo-transfectants the four forms of FGF-2 were detected, in the pRF11AEN-transfectants the 18 kDa form was predominant while no FGF-2 was detected in the pIgbFGF-transfected cells ( Figure  4 ). These results were obtained repetitively with several cellular extracts corresponding to each type of transfection.
We observed a partial switch of the FGFR-2 transcripts in the FGF-2-transfected cells, whatever the plasmid encoding FGF-2 we used. In fact, only a fraction of the transcripts, corresponding to the three Ig domain form, switched from IIIb to IIIc (Figure 5c , e, g and h). This partial switch induced by endogenously produced FGF-2 was strictly similar to the switch induced by exogenously added FGF-1 or FGF-2. Moreover, this switch was observed only when the cells were subcon¯uent at the time of harvesting. When the cells returned to con¯uency, they showed only IIIb (Figure 5d and f) . For each type of transfection, we analysed the pool of transfected cells plus several clones and the data were strictly similar. In contrast, the pSGneo-transfected cells expressed only IIIb transcripts, whatever their con¯uency (Figure 5a) .
The IIIb to IIIc switch induced in SVK14 cells by endogenous FGF-2 was correlated to a transient loss of epithelial characteristics. This was analysed in more details with the pRF11AEN-and the pIgbFGFtransfectants. While the pSGneo-transfected cells showed a typical epithelial morphology (Figure 6e ), the FGF-2-transfected cells lost their cell contacts, became scattered and acquired a ®broblastic morphology as long as they were subcon¯uent (Figure 6f ), and this was correlated to the appearance of IIIc transcripts. When the FGF-2-transfected cells returned to con¯uency, they recovered an epithelial phenotype (not shown) and IIIb transcripts (Figure 5f ). This morphological transition induced by endogenous FGF-2 was accompanied by a change in the distribution of desmoplakin, a desmosome-speci®c protein (Cowin et al., 1985) . Desmoplakin in pSGneo-SVK14 cells forms a typical punctuate array along cell boundaries ( Figure  6a ) while it was distributed as intracellular spots in FGF-2-transfected cells as long as they were subconuent ( Figure 6b ). We also searched for vimentin, a marker of mesenchymal cells. We found very few positive cells (about one out of 20) among the subcon¯uent FGF-2-transfectants (Figure 6c ). Con- Endogenous FGF-1 produced similar eects compared to endogenous FGF-2. In fact, a partial switch for the form with three Ig domains of the FGFR-2 was observed in SVK14 cells transfected with an expression vector coding for FGF-1 (pFGF-1neo), provided the cells were subcon¯uent at the time of harvesting (Figure 5b ).
Exogenous FGF-1, but not exogenous FGF-2, induces a IIIb to IIIc switch of the FGFR-2 in NBT-II cells NBT-II cells were cultured at low density, they received one addition of FGF-1 or FGF-2 and the FGFR-2 transcripts were analysed after various times. We observed that FGF-1 induced a partial and transient IIIb to IIIc switch (Figure 7a to d) . This was accompanied by a reversible scattering of the cells (Figure 8a and b) . Control NBT-II cells cultured in the same conditions, but without FGF, had only IIIb transcripts ( Figure 7a ). As in SVK14 cells the switch was evident 1 h after addition of FGF-1 and was only transient as it was no more observed two days later.
This switch was always partial, concerning about 50% of the transcripts for the three forms of the extracellular domain of FGFR-2. Even when subconuent NBT-II cells were exposed to FGF-1 for 7 days, with one addition of FGF-1 per day, no more than half of the transcripts had switched from IIIb to IIIc (Figure 7c ). In contrast, subcon¯uent NBT-II cells cultured in the presence of FGF-2 remained IIIb.
Con¯uent NBT-II cells showed only IIIb transcripts and no switch was observed when these con¯uent cells received FGF-1 (Figure 7d ). (Figure 9d ). This appeared clearly when we used P9 and P8 for PCR ampli®cation of Ig domains 2 and 3 of the FGFR-2 (Figure 9g, h) .
The switch of the FGFR-2 was accompanied by a change in the cell phenotype. The pool of FGF-1-transfected cells, as well as the clones, appeared dissociated with ®broblast-like morphology as long as the cells were subcon¯uent (Figure 8c ). However when these cells were grown at con¯uency, they returned to epithelial phenotype (Figure 8d ). These changes were not due to the neomycin selection used, as cells transfected with pSGneo remained epithelial (not shown). These clones were kept in culture for 6 months and they maintained the same pattern characterized by an alternance between a mixture of IIIb and IIIc transcripts, accompanied by the appearance of ®broblastic cells, and only IIIb transcripts, correlated to epithelial features. However two of these clones switched de®nitively and completely to IIIc and to a ®broblastic morphology after several weeks in culture (S116/3 and S116/5).
The mixture of IIIb and IIIc transcripts in the NBT-II cells producing FGF-1 upon transfection with an expression vector does not seem to be linked to a mixture of two types of cells as all the clones showed a mixture of IIIb and IIIc as the pool of transfected cells. In order to see if this switch transiently induced by the FGF-1 was cell cycle-dependent, we prepared RNA from cells detached by gentle pipeting, corresponding mainly to mitotic cells. The experiment was repeated three times and as shown in Figure 9f , the FGFR-2 transcripts in these cells were predominantly IIIc.
NBT-II cells were also transfected with the various expression vectors encoding FGF-2. Whatever the form of FGF-2 endogenously produced, the cells remained epithelial and they expressed only IIIb transcripts (Figure 9e ), thus con®rming that FGF-2 cannot induce FGFR-2 switch in NBT-II cells.
Exogenous or endogenous FGF-1, but not FGF-2, induces a IIIb to IIIc switch of the FGFR-3 in SVK14 cells
Similar experiments as described above were conducted for analysis of the FGFR-3 transcripts. In accordance with previous reports , control showed only IIIb transcripts in SVK14 cells (Figure 10a ) and a mixture of IIIb and IIIc transcripts in MRC5 cells, a human ®broblastic cell line ( Figure  10d ). SVK14 cells, cultured either at low or at high density, received one addition of FGF-1 or FGF-2 and the FGFR-3 transcripts were analysed at dierent times after addition of the growth factor, ranging from 1 ± 24 h. The data indicated that FGF-1 induces a partial switch of the FGFR-3 from IIIb to IIIc, provided the cells were subcon¯uent (Figure 10b and c). This switch was transient: it was evident 1 h or 3 h after adding FGF-1 but was no more observed after 7 h. SVK14 cells expressing endogenous FGF-1 upon transfection with pFGF-1neo also showed a mixture of IIIb and IIIc transcripts provided the cells were collected at subcon¯uency (not shown).
In contrast, no switch was observed at various times after addition of exogenous FGF-2 (Figure 10c) . Moreover, SVK14 cells expressing FGF-2 upon transfection with pFGF-2neo, pIgbFGF, pRF11AEN or pRFEneo showed only IIIb transcripts (Figure 10f, g,  h) , thus con®rming that FGF-2 did not induce a change in the FGFR-3 exon III splicing choice in these cells.
Discussion
We describe here a reversible exon III splicing switch that was induced in FGFR-2 and -3 by FGF-1 and/or FGF-2, depending on the cell line that we used. This switch occurred as early as 1 h after adding exogenous FGF.
Several arguments suggest that the IIIb to IIIc switch in the FGFR-2 under the in¯uence of FGFs is a receptor-mediated process, even when endogenous FGFs are involved. The splicing switch in FGFR-2 was induced upon addition of FGF-1 or FGF-2 in SVK14 cells while it was observed only with FGF-1 in NBT-II cells. Moreover, FGFs produced endogenously upon transfection had eects strictly similar to those of exogenous FGFs. During this study, we used another human epithelial cell line, the SW948 colon carcinoma, that also showed a switch of the FGFR-2 under the in¯uence of FGF-1 but not of FGF-2 (data not shown). The dierence between SVK14 and NBT-II seems to be correlated to the fact that they carry dierent FGFRs with dierent ligand-binding capacities. The SVK14 cells express the FGFR-1 (which binds FGF-1 as well as FGF-2) but they do not express the FGFR-2. In contrast, NBT-II cells, as most of the epithelial cells, express the IIIb variant of FGFR-2, which has high anity only for FGF-1, but they do not express the FGFR-1. We don't know the level of expression of FGFR-3 or -4 in these two cell lines but it should be underlined that these two FGF receptors would not contribute to bind FGF-2 eciently. In fact, FGFR-3/IIIb, the only FGFR-3 variant expressed by the epithelial cells binds only FGF-1 (Chellaiah et al., 1994) , while FGFR-4 binds FGF-1 with high anity but shows low anity for FGF-2 (Vainikka et al., 1992) . Along this line, we have observed that when NBT-II cells, stably transfected with expression vector encoding the human FGFR-1 (WennstroÈ m et al., 1991) or the human IIIc variant of the FGFR-2 (Houssaint et al., 1990) , were treated with exogenous FGF-2, they showed a mixture of IIIb and IIIc transcripts and they became dissociated (our unpublished observation). Though FGF-2 does not induce exon III switch in NBT-II, it stimulates cell growth on these cells (ValleÂ s et al., 1990) . This is most probably correlated to the fact that although FGFR-2/IIIb is a high anity receptor for FGF-1 and FGF-7, it also binds FGF-2 with lower anity (Miki et al., 1992) .
Exon III switch described here was dependent on cell con¯uency, whether it was induced by exogenous or endogenous FGFs. Exogenous FGF induced the switch only if the cells were subcon¯uent when adding the growth factor. The switch induced by endogenous FGF also depended on cell density. We observed with the two cell lines induced to produce endogenous FGF upon transfection an oscillation between a mixture of IIIb and IIIc, when the cells were subcon¯uent and only IIIb transcripts when the cells returned to con¯uency. In contradiction with others (Savagner et al., 1994) , we did not observe that the cell con¯uency per se, without adding FGF, induce an exon III switch. Con¯uent NBT-II or SVK14 cells, as subcon¯uent cells, showed only IIIb transcripts.
Moreover, we show that there is a link between the exon III switch and the cell cycle. The switch was always partial as it did not aect all the transcripts, whatever the cell line or the FGF that we used and whether the FGF was endogenously produced or exogenously added. Analysis of clones has clearly shown that this pattern was not due to a mixture of cells with only IIIb and cells with only IIIc transcripts. One possible explanation is that the switch produced by the FGF is cell cycle-dependent, so that in a nonsynchronized population there would be a mixture of cells with dierent exon III choice. In favour of this hypothesis, a population enriched in mitotic cells showed almost exclusively IIIc transcripts. Another argument in favour of a cell cycle-dependency is that after one addition of exogenous FGF, the switch was observed during the ®rst 5 h, was no more detectable after 7 or 10 h but was observed again after 20 h. We also analysed in this study the in¯uence of FGF on the splicing choice of exon III in the FGFR-3. A switch from IIIb to IIIc was induced only by FGF-1, but not by FGF-2, in SVK14 cells. The dierence between the two ligands is apparently not due to a defect of internalization of the FGF-2 as SVK14 cells express receptors for FGF-1 as well as for FGF-2.
Whether or not the switch involves a translocation of the FGF in the nucleus remains an unanswered question. Regarding this point, it is interesting to underline that nuclear translocation of FGF-1 and FGF-2 has been shown to be cell cycle-dependent. FGF-2 is translocated to the nucleus by two independent processes. One route follows the exposure of the cells to the 18 kDa FGF-2. In this exogenous pathway, the FGF-2 enters the nucleus of growing cells during the G 1 /S transition and it accumulates preferentially in the nucleolus (Bouche et al., 1987; Baldin et al., 1990) . The second route (endogenous pathway) involves intracellular distribution of high Mr forms of FGF-2, initiated at CUG start codons (Prats et al., 1989; Florkiewicz et al., 1989; Bugler et al., 1991) . A nuclear location has also been reported for FGF-1 but, as for FGF-2, may involve more than one mechanism. A nuclear localization sequence has been characterized for FGF-1, but translocation to the nucleus appears to be inhibited (Zhan et al., 1992) . In contrast, exogenous FGF-1 is translocated to the nucleus during the entire G 1 period of the cell cycle by a receptor-dependent process (Zhan et al., 1992; Prudovsky et al., 1996) . Nuclear and nucleolar localization has also been reported for FGF-3 (Kiefer and Dickson, 1995) . The presence of FGFs in the nucleus is likely to be important in their biological functions. Internalization of FGF-1 is essential for stimulation of cell division (Wiedlocha et al., 1994) . FGF-2 can aect gene transcription in cell-free systems (Nakanishi et al., 1992) . FGF-2 taken in the nucleolus appears to increase the transcription of genes encoding ribosomal RNA (Bouche et al., 1987) . Thus, nuclear and nucleolar localization of FGFs may aect the splicing of genes such as the FGF receptor genes.
The switch in splicing choice induced by exogenous FGF-1 and/or FGF-2 was accompanied by a reversible scattering eect correlated to the loss of desmosomes and acquisition of ®broblast-like morphology. Production of endogenous FGF also resulted in reversible morphological transition as the cells oscillated between epithelial and mesenchymal phenotype, according to the cell con¯uency. However, it should be underlined that these changes did not correspond to a true epitheliomesenchymal transition (EMT). Most of the cells did not acquire vimentin, a marker of mesenchymal cells. This is in accordance with data from Migdal et al. (1995) that showed that activation of a transfected FGFR-1 by FGF-2, in MDCK epithelial cells, was accompanied by a scatter eect and changes in the actin cytoskeleton but there was no true dierentiation in ®broblasts as cells did not lose their cytokeratins ®laments.
We previously described an exon III switch for FGFR-2 and -3 induced by activation of c-Fos which appears dierent compared to the switch induced by FGF. It was de®nitive, involved a long term activation of c-Fos (24 h), occurred only after several cell passages, was not dependent on cell con¯uency and was correlated to a de®nitive EMT. In contrast, the switch induced by FGF was transient, occurred very rapidly after adding FGF, was dependent on cell con¯uency and was correlated to a transient scatter eect rather than to a true EMT. Both situations exist in vivo, in physiological or pathological situations: de®nitive EMT occurs for example during ontogenesis and in tumor progression while transient EMT occurs during the cicatrization process.
Materials and methods
Cell culture
Several cell lines, obtained from the American Tissue Type Collection were used in this study: SVK14 cells (human keratinocytes transformed by simian virus 40), HeLa (cervix carcinoma), MRC5 (human lung ®broblasts) and NBT-II (rat bladder carcinoma). They were maintained in culture in Dulbecco's minimum essential medium containing 10% foetal calf serum (standard medium). The cells were seeded either at low density (1.5610 5 cells per 10 cm dish) or at con¯uency (2610 6 cells per dish). For FGF induction studies, FGF-1 (Human recombinant FGF-1, 20 ng/ml) or FGF-2 (Human recombinant FGF-2, 18 kDa, 10 ng/ml) was added one day after plating to standard medium. RNA was prepared at various times after one addition of FGF.
Transfections
The plasmid pFGF-1neo was obtained by placing a 4004 bp bovine FGF-1 cDNA clone (Halley et al., 1988) under the control of the simian virus 40 early promoter in a version of the pKCR3 expression vector (Matrisian et al., 1986 ) containing a neomycine resistance gene. The plasmid pFGF-2neo was obtained by inserting a full length human FGF-2 cDNA (Prats et al., 1989) in the pKCR3 expression vector containing a neomycin resistance gene. The plasmid pRF11AEN, containing FGF-2 cDNA initiated at the AUG start and the plasmid pRFEneo, containing FGF-2 cDNA initiated at the CUG1 start were kindly provided by H Prats (Prats et al., 1989) . The plasmid pIg bFGF, in which sequences specifying an immunoglobulin signal peptide of 19 amino acids were fused to the bFGF (FGF-2) cDNA was kindly provided by S Rogelj (Rogelj et al., 1988) . For control, cells were transfected with 1 mg of pSGneo (which contains a neomycin resistance gene alone). Co-transfection with plasmid pSGneo was used with pIgbFGF (1 mg and 20 mg/10 6 cells, respectively). NBT-II and SVK14 cells were transfected by the calcium phosphate precipitation technique. After 24 h in culture, the cells were split 1 : 4 and cultured therafter in presence of the neomycin analogue G418 (400 mg/ml for NBT-II cells, 800 mg/ml for SVK14 cells). After 3 weeks, the colonies from three dishes were pooled. Prior to pooling some individual colonies were picked using cylinders and expanded in selective medium for 2 more weeks and then passaged in standard medium.
Mitotic selection
Mitotic cells were selected from a clone of NBT-II cells transfected with the pFGF-1neo expression vector (clone S116/7). Eight 150 cm 2¯a sks of cells were grown to onehalf con¯uency. After rinsing twice the monolayers with complete medium, 10 ml of the same medium was added and the cells were incubated at 378c for 30 mn. Flasks were then shaken to remove mitotic cells which were pelleted and treated for RNA extraction.
RNA extraction and Northern blot analysis
The one-step acid guanidinium isothiocyanate/phenol/ chloroform extraction method was used for RNA extraction (Chomczynski and Sacchi, 1987) . For Northern blot analysis, total RNA (20 mg) was run on a 1.2% formaldehyde agarose gel, blotted onto a Hybond-N nylon membrane (Amersham) by capillary transfer and baked at 808C. Hybridization was performed with a 2.7 kb EcoRI ± EcoRI fragment of the human FGFR-1 cDNA, nt 589 ± 3337, kindly provided by L Claesson-Welsh (Wennstrom et al., 1991) or with a 2.3 kb fragment of the human FGFR-2 cDNA, nt 1 ± 2291 (Houssaint et al., 1990) . To detect FGF-1 mRNA expression, we used as probe a 1.7 kb fragment corresponding to the full length bovine FGF-1 cDNA (Halley et al., 1988) . These probes were 32 P-labelled by using a multiprime DNA labelling system (Promega). RNA blots were reprobed with a mouse b actin cDNA as a control for equal lane loading and transfer.
RT ± PCR analysis of IIIb and IIIc variants for FGFR-2 and FGFR-3 PCR were performed on cDNA reverse-transcribed from total cytoplasmic RNA as described . Speci®c primers were used to amplify sequences coding for the extracellular domain of FGFR-1, -2 or -3. Their locations are indicated in Figure 1 . For human FGFR-1, we used P1 (5'-AACTGCAGAACTGGGATG-3') and P2 (5'-GATGATCTCCTGGTACAG-3'). To amplify rat FGFR-1, we used P3 (5'-AATGATCTCCAGGTAGAG-3') and P4 (5'-AACCGCAGAACTGGGATG-3'), deduced from the mouse FGFR-1 sequence. Hybridization was performed with a 2.7 kb EcoRI ± EcoRI fragment of the human FGFR-1 cDNA. For human FGFR-2, we used P5 (5'-CGCCTTCGGTTCCTGAG-3') and P6 (5'-GTCTGGGGAAGCTGTAAT-3'). For rat FGFR-2, we used either P7 (5'-GATACCACTTTAGAACAGA-3') and P8 (5'-ATCTGGGGAAGCCGTGAT-3') or P9 (5'-AA-CACTGTGAAGTTCCGCTG-3') and P8. The PCR products were subjected to restriction enzyme mapping with HincII and AvaI and the fragments were separated by agarose gel electrophoresis, transferred to a Hybond-N + nylon membrane and hybridized with a 2.3 kb human FGFR-2 cDNA fragment. Ampli®cation of the sequences coding for Ig domain 3 of human FGFR-3 was performed as described previously , using P10 (5'-GCACCGGCCCATCCTGCAGGCGG-3') and P11 (5'-TACACACTGCCCGCCTCGTCAGC-3'). The IIIb and IIIc variants were distinguished by using HaeII and TaqI and hybridization was performed using a mixture of exon IIIb-and exon IIIc-derived PCR products . For all RT ± PCR analysis, the amount of PCR product loaded in each lane was equivalent as described in details in Champion-Arnaud et al. (1991) and several exposition times were done for each autoradiography to make sure that any weak signal could be detected.
FGF-1 and FGF-2 expression analysis
Production of FGF-1 by untransfected and transfected NBT-II cells was quanti®ed using a second antibody solid phase enzyme immunoassay as described (Oliver et al., 1992) . Assays were done on total cellular extracts.
Immunoblot analysis of FGF-2 content was performed on cell extracts of untransfected and transfected SVK14 cells as previously described (Bugler et al., 1991) using an anti-FGF-2 antibody from Oncogene Science (Manhasset, NY, USA).
Immuno¯uorescence assay
Cells were seeded on glass coverslips. The following day, they were ®xed with methanol for 5 min at 7208C, followed by acetone for 1 min, before processing for immunostaining. Mouse monoclonal antibodies were against desmoplakin (Cowin et al., 1985) or against vimentin (Amersham, Buckinghamshire, UK). Primary mouse antibodies were applied for 1 h, followed by several washes in phosphate-buered saline and a 30 min incubation with¯uorescein-conjugated goat anti-mouse IgG (Pasteur Institute, Paris, France).
